Humacyte HUMA
NASDAQ HUMA
$0.41 +0.01 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Humacyte (HUMA) Long-Term Investments (2020 - 2021)

Updated

Humacyte's Long-Term Investments came in at $100.03 million for Q2 2021, unchanged from the prior quarter.

Analysis

Humacyte (HUMA) Long-Term Investments (2020 - 2021) Analysis & Trends

At the end of FY2020, Humacyte's Long-Term Investments was $100.02 million.

  • Business Quant data shows HUMA's Long-Term Investments at $100.03 million (Q1 2021), $100.02 million (Q4 2020) and $99.98 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 266.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.56 Bn
10 Humacyte 97.33 Mn -101.11 Mn -825,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 100.03 Mn
Mar 31, 2021 100.03 Mn
Dec 31, 2020 100.02 Mn
Sep 30, 2020 99.98 Mn
API Access

Humacyte Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=HUMA&period=max&api_key=YOUR_API_KEY